Anzeige
Mehr »
Login
Samstag, 23.11.2024 Börsentäglich über 12.000 News von 677 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CRAU | ISIN: SE0015988373 | Ticker-Symbol: 7D2A
Frankfurt
22.11.24
08:11 Uhr
1,012 Euro
+0,018
+1,81 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
SEDANA MEDICAL AB Chart 1 Jahr
5-Tage-Chart
SEDANA MEDICAL AB 5-Tage-Chart
RealtimeGeldBriefZeit
1,0261,06422.11.
1,0341,04822.11.

Aktuelle News zur SEDANA MEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
24.10.Sedana Medical AB: Sedana Medical AB's Interim report January-September 202464Raising our 2024 sales guidance and integrating our European trial into the US submission - strengthening our file, but extending timelines Third quarter 2024Net sales for the quarter totaled MSEK 39.7...
► Artikel lesen
SEDANA MEDICAL Aktie jetzt für 0€ handeln
23.07.Sedana Medical AB: Sedana Medical AB's Interim report January-June 202488Enrolment of both US clinical trials completed, on track for first results in 2H. Second quarter 2024 Net sales for the quarter totaled MSEK 41.1 (37.3), equivalent to an increase of 10% compared...
► Artikel lesen
22.07.Sedana Medical AB: Sedana Medical to acquire its main supplier to take control of supply chain and reduce cost of goods217Sedana Medical AB (publ) announces it has today entered into an agreement to acquire Innovatif Cekal, the supplier of the company's main product (Sedaconda ACD). The acquisition will enable better control...
► Artikel lesen
16.07.Invitation to presentation of Sedana Medical's interim report for the second quarter 20242
29.05.Sedana Medical completes patient recruitment for its clinical program in the US274STOCKHOLM, May 29, 2024 /PRNewswire/ -- Sedana Medical AB (publ) announces that all 235 randomized patients have been recruited for its INSPiRE-ICU 2 phase III clinical trial in the United...
► Artikel lesen
25.04.Sedana Medical completes patient recruitment for INSPiRE-ICU 1 clinical trial in the US247STOCKHOLM, April 25, 2024 /PRNewswire/ -- Sedana Medical AB (publ) announces that all 235 randomized patients have been recruited for its INSPiRE-ICU 1 phase III clinical trial in the United...
► Artikel lesen
25.04.Sedana Medical AB: Sedana Medical AB's Interim report January-March 2024144Off to a strong start with record sales in Q1 First quarter 2024 Net sales for the quarter totalled MSEK 48.8 (37.8), equivalent to an increase of 29% compared to the same quarter 2023. At constant...
► Artikel lesen
7 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
2,1,1